Relying on well-known professors from the University of Hong Kong, it brings together professionals in chemistry, biology, and computer science. Serilink Biotechnology Co., Ltd. (Serilink) focuses on the biomedical industry, makes full use of the advantages of talents, capital, and policies in the Greater Bay Area, and through the combination of technology, capital, and market, is committed to applying innovative technology to practice and creating The leading conjugation technology platform promotes the research and development process of biomedicine (ADC/PDC/ARC and other drugs) in the Greater Bay Area, and catches up with the wave of vigorous development of biomedicine with counterparts in the Greater Bay Area.

Serilink has the in-house patented OPA LinkTechTM core technology platform, forming a complete platform-based development system, which can stably prepare various plug and play (plug and play) OPA-kit products on a large scale, including OPA-fluorescence, OPA-PEG, OPA-toxin, OPA-polymer, OPA-Click chemistry, etc.

The platform-based development system enables Serilink to better meet the diverse needs of scientific researchers. On the basis of providing plug-play kits, it can customize various laboratory products and services according to customer needs, realize localization substitution, and help biomedical research. develop.

Independent patented technology ensures that on the basis of meeting the needs of scientific researchers, it further provides commercial R&D services for enterprises.